TIL
Instil Bio, Inc.
A Dallas biotech firm working on a personal kind of cancer immunotherapy: it takes a patient's own immune cells that have already wandered into a tumor, multiplies them into an army in the lab, and infuses them back to hunt down the cancer. Founded in 2018, the company also developed a CoStAR platform meant to give those engineered cells an extra "on" switch when they meet a tumor. Its name plays on "instil" — boosting the body's own natural immune response to fight disease.
CUSIP: 45783C101HealthcareUS1 holder
Total Value
$11.98M
Total Shares
2.59M
Net Share Change
+1.26M
Activity
1 buying
Investor
Value
Shares
Weight
Change
